P53 is usually inactivated during cancer development, which not only losses its suppressive tumor activities but often results in additional oncogenic functions, such as promoting cancer cell proliferation and metastasis, and inhibiting cell apoptosis [21,22]. The gene discussed is TP53; the disease is cancer.